semaglutide or tirzepatide Semaglutide, recommended as first-line treatment of obesity and most of its complications in new guidance Tirzepatide vs. Semaglutide: Which is

Ingredients: Water, Methylpropanediol, Glycerin, Beta-Glucan, Dimethicone, Titanium Dioxide, Niacinamide, Cyclopentasiloxane, Betaine, Polyglycerin-3, Eclipta Prostrata Leaf Extract, Laminaria Japonica Extract, 1,2-Hexanediol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Sodium Polyacrylate, Ethylhexyl Stearate, Isohexadecane, Panthenol, Dimethiconol, Hydroxyacetophenone, Butylene Glycol, Polysorbate 80, Centella Asiatica Extract, Ficus Carica (Fig) Fruit Extract, Fragrance, Glutathione, Glycyrrhiza Glabra (Licorice) Root Extract, Lactobacillus/Rice Ferment, Sorbitan Oleate, Triethoxycaprylylsilane, Trideceth-6, Hydrogenated Lecithin, Fructooligosaccharides, Hydrogenated Polyisobutene, Squalane, Disodium Edta, Argania Spinosa Kernel Oil, Isononyl Isononanoate, Polyglyceryl-10 Stearate, Amaranthus Caudatus Seed Extract, Butyrospermum Parkii (Shea) Butter, Cetearyl Alcohol, Panax Ginseng Root Extract, Polyglyceryl-2 Dipolyhydroxystearate, Stearic Acid, Ulmus Davidiana Root Extract, Hydrolyzed Hyaluronic Acid, Inulin Lauryl Carbamate, Carbomer, Pearl Powder, Ceramide Np, Polysorbate 20, Disodium Stearoyl Glutamate, Palmitoyl Pentapeptide-4

BPC-157 is generally well tolerated, with no major known side effects and no significant interactions with most medications

Patients who maintain adequate protein intake preserve lean mass significantly better than those who don't

Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in [PMID: 38497771] Laboratory literature summary: Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in recipients of liver transplants